Hasil Pencarian - Lars Bastholt
- Menampilkan 1 - 7 hasil dari 7
-
1
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized contro... oleh Lærke K. Tolstrup, Helle Pappot, Lars Bastholt, Sören Möller, Karin B. Dieperink
Diterbitkan 2022-01-01
Artikel -
2
-
3
-
4
-
5
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial oleh Lærke K. Tolstrup, Lars Bastholt, Karin B. Dieperink, Sören Möller, Ann-Dorthe Zwisler, Helle Pappot
Diterbitkan 2020-10-01
Artikel -
6
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma oleh Gabriella Liszkay, Catriona McNeil, Michele Maio, Vanna Chiarion-Sileni, Luc Thomas, Andrzej Mackiewicz, Michelle Del Vecchio, Ana Arance, Laurent Mortier, Lars Bastholt, Brigitte Dreno, Marta Nyakas, Michael Smylie, Christoph Hoeller, Virginia Ferraresi, Florent Grange, Joanna Pikiel, Fareeda Hosein, Burcin Simsek
Diterbitkan 2020-06-01
Artikel -
7
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II st... oleh Sophie Leboulleux, Ellen Kapiteijn, Saskia Litière, Patrick Schöffski, Yann Godbert, Patrice Rodien, Barbara Jarzab, Domenico Salvatore, Sylvie Zanetta, Jaume Capdevila, Lars Bastholt, Christelle De La Fouchardiere, Yassine Lalami, Stéphane Bardet, Frank Cornélis, Marek Dedecjus, Thera Links, Ward Sents, Martin Schlumberger, D. Laura Locati, Katie Newbold
Diterbitkan 2024-06-01
Artikel